| Medgenics gets US FDA nod to begin Epodure trial for anaemia treatment in ... - pharmabiz.com |
|
|
pharmabiz.com Treatment of anaemia in dialysis patients with Epodure is intended to replace frequent injections of EPO or other erythropoietic stimulating agents (ESAs). “This timely acceptance of our first Investigational New Drug (IND) to the FDA marks a |